0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Radiotherapy Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-6I11970
Home | Market Reports | Health| Health Conditions| Cancer
Global Cancer Radiotherapy Market Research Report 2022
BUY CHAPTERS

Global Cancer Radiotherapy Market Research Report 2022

Code: QYRE-Auto-6I11970
Report
August 2022
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Radiotherapy is a type of ionising radiation (high energy) that destroys the cancer cells in the treated area by damaging the DNA of these cells.
Highlights

The global Cancer Radiotherapy market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for Cancer Radiotherapy is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Cancer Radiotherapy is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global manufacturers of Cancer Radiotherapy include Siemens Healthineers, Elekta, Accuray Incorporated, IBA, ViewRay Technologies, Hitachi Ltd., iCAD, Inc., IsoRay and Mevion Medical Systems, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

The global market for Cancer Radiotherapy in Hospitals is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, External Beam Radiotherapy, which accounted for % of the global market of Cancer Radiotherapy in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Cancer Radiotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Radiotherapy.
The Cancer Radiotherapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cancer Radiotherapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Radiotherapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Siemens Healthineers
Elekta
Accuray Incorporated
IBA
ViewRay Technologies
Hitachi Ltd.
iCAD, Inc.
IsoRay
Mevion Medical Systems
Panacea Medical Technologies
P-cure Ltd.
ZEISS Group
Product Type Insights
Global markets are presented by Cancer Radiotherapy type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Cancer Radiotherapy are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Cancer Radiotherapy segment by Type

External Beam Radiotherapy
Internal Beam Radiotherapy
Systemic Radiotherapy
Intravenous Radiotherapy
Oral Radiotherapy
Instillation Radiotherapy
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Cancer Radiotherapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Cancer Radiotherapy market.

Cancer Radiotherapy segment by Application

Hospitals
Independent Radiotherapy Centers
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cancer Radiotherapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Radiotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Cancer Radiotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Cancer Radiotherapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Radiotherapy.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cancer Radiotherapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cancer Radiotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
1 Cancer Radiotherapy Market Overview
1.1 Product Overview and Scope of Cancer Radiotherapy
1.2 Cancer Radiotherapy Segment by Type
1.2.1 Global Cancer Radiotherapy Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 External Beam Radiotherapy
1.2.3 Internal Beam Radiotherapy
1.2.4 Systemic Radiotherapy
1.2.5 Intravenous Radiotherapy
1.2.6 Oral Radiotherapy
1.2.7 Instillation Radiotherapy
1.3 Cancer Radiotherapy Segment by Application
1.3.1 Global Cancer Radiotherapy Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Independent Radiotherapy Centers
1.4 Global Cancer Radiotherapy Market Size Estimates and Forecasts
1.4.1 Global Cancer Radiotherapy Revenue 2017-2028
1.4.2 Global Cancer Radiotherapy Sales 2017-2028
1.4.3 Cancer Radiotherapy Market Size by Region: 2017 Versus 2021 Versus 2028
2 Cancer Radiotherapy Market Competition by Manufacturers
2.1 Global Cancer Radiotherapy Sales Market Share by Manufacturers (2017-2022)
2.2 Global Cancer Radiotherapy Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Cancer Radiotherapy Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Cancer Radiotherapy Manufacturing Sites, Area Served, Product Type
2.5 Cancer Radiotherapy Market Competitive Situation and Trends
2.5.1 Cancer Radiotherapy Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cancer Radiotherapy Players Market Share by Revenue
2.5.3 Global Cancer Radiotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cancer Radiotherapy Retrospective Market Scenario by Region
3.1 Global Cancer Radiotherapy Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Cancer Radiotherapy Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Cancer Radiotherapy Market Facts & Figures by Country
3.3.1 North America Cancer Radiotherapy Sales by Country
3.3.2 North America Cancer Radiotherapy Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Cancer Radiotherapy Market Facts & Figures by Country
3.4.1 Europe Cancer Radiotherapy Sales by Country
3.4.2 Europe Cancer Radiotherapy Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cancer Radiotherapy Market Facts & Figures by Region
3.5.1 Asia Pacific Cancer Radiotherapy Sales by Region
3.5.2 Asia Pacific Cancer Radiotherapy Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Cancer Radiotherapy Market Facts & Figures by Country
3.6.1 Latin America Cancer Radiotherapy Sales by Country
3.6.2 Latin America Cancer Radiotherapy Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Cancer Radiotherapy Market Facts & Figures by Country
3.7.1 Middle East and Africa Cancer Radiotherapy Sales by Country
3.7.2 Middle East and Africa Cancer Radiotherapy Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cancer Radiotherapy Historic Market Analysis by Type
4.1 Global Cancer Radiotherapy Sales Market Share by Type (2017-2022)
4.2 Global Cancer Radiotherapy Revenue Market Share by Type (2017-2022)
4.3 Global Cancer Radiotherapy Price by Type (2017-2022)
5 Global Cancer Radiotherapy Historic Market Analysis by Application
5.1 Global Cancer Radiotherapy Sales Market Share by Application (2017-2022)
5.2 Global Cancer Radiotherapy Revenue Market Share by Application (2017-2022)
5.3 Global Cancer Radiotherapy Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Siemens Healthineers
6.1.1 Siemens Healthineers Corporation Information
6.1.2 Siemens Healthineers Description and Business Overview
6.1.3 Siemens Healthineers Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Siemens Healthineers Cancer Radiotherapy Product Portfolio
6.1.5 Siemens Healthineers Recent Developments/Updates
6.2 Elekta
6.2.1 Elekta Corporation Information
6.2.2 Elekta Description and Business Overview
6.2.3 Elekta Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Elekta Cancer Radiotherapy Product Portfolio
6.2.5 Elekta Recent Developments/Updates
6.3 Accuray Incorporated
6.3.1 Accuray Incorporated Corporation Information
6.3.2 Accuray Incorporated Description and Business Overview
6.3.3 Accuray Incorporated Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Accuray Incorporated Cancer Radiotherapy Product Portfolio
6.3.5 Accuray Incorporated Recent Developments/Updates
6.4 IBA
6.4.1 IBA Corporation Information
6.4.2 IBA Description and Business Overview
6.4.3 IBA Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.4.4 IBA Cancer Radiotherapy Product Portfolio
6.4.5 IBA Recent Developments/Updates
6.5 ViewRay Technologies
6.5.1 ViewRay Technologies Corporation Information
6.5.2 ViewRay Technologies Description and Business Overview
6.5.3 ViewRay Technologies Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.5.4 ViewRay Technologies Cancer Radiotherapy Product Portfolio
6.5.5 ViewRay Technologies Recent Developments/Updates
6.6 Hitachi Ltd.
6.6.1 Hitachi Ltd. Corporation Information
6.6.2 Hitachi Ltd. Description and Business Overview
6.6.3 Hitachi Ltd. Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Hitachi Ltd. Cancer Radiotherapy Product Portfolio
6.6.5 Hitachi Ltd. Recent Developments/Updates
6.7 iCAD, Inc.
6.6.1 iCAD, Inc. Corporation Information
6.6.2 iCAD, Inc. Description and Business Overview
6.6.3 iCAD, Inc. Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.4.4 iCAD, Inc. Cancer Radiotherapy Product Portfolio
6.7.5 iCAD, Inc. Recent Developments/Updates
6.8 IsoRay
6.8.1 IsoRay Corporation Information
6.8.2 IsoRay Description and Business Overview
6.8.3 IsoRay Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.8.4 IsoRay Cancer Radiotherapy Product Portfolio
6.8.5 IsoRay Recent Developments/Updates
6.9 Mevion Medical Systems
6.9.1 Mevion Medical Systems Corporation Information
6.9.2 Mevion Medical Systems Description and Business Overview
6.9.3 Mevion Medical Systems Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Mevion Medical Systems Cancer Radiotherapy Product Portfolio
6.9.5 Mevion Medical Systems Recent Developments/Updates
6.10 Panacea Medical Technologies
6.10.1 Panacea Medical Technologies Corporation Information
6.10.2 Panacea Medical Technologies Description and Business Overview
6.10.3 Panacea Medical Technologies Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Panacea Medical Technologies Cancer Radiotherapy Product Portfolio
6.10.5 Panacea Medical Technologies Recent Developments/Updates
6.11 P-cure Ltd.
6.11.1 P-cure Ltd. Corporation Information
6.11.2 P-cure Ltd. Cancer Radiotherapy Description and Business Overview
6.11.3 P-cure Ltd. Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.11.4 P-cure Ltd. Cancer Radiotherapy Product Portfolio
6.11.5 P-cure Ltd. Recent Developments/Updates
6.12 ZEISS Group
6.12.1 ZEISS Group Corporation Information
6.12.2 ZEISS Group Cancer Radiotherapy Description and Business Overview
6.12.3 ZEISS Group Cancer Radiotherapy Sales, Revenue and Gross Margin (2017-2022)
6.12.4 ZEISS Group Cancer Radiotherapy Product Portfolio
6.12.5 ZEISS Group Recent Developments/Updates
7 Cancer Radiotherapy Manufacturing Cost Analysis
7.1 Cancer Radiotherapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cancer Radiotherapy
7.4 Cancer Radiotherapy Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cancer Radiotherapy Distributors List
8.3 Cancer Radiotherapy Customers
9 Cancer Radiotherapy Market Dynamics
9.1 Cancer Radiotherapy Industry Trends
9.2 Cancer Radiotherapy Market Drivers
9.3 Cancer Radiotherapy Market Challenges
9.4 Cancer Radiotherapy Market Restraints
10 Global Market Forecast
10.1 Cancer Radiotherapy Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cancer Radiotherapy by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Cancer Radiotherapy by Type (2023-2028)
10.2 Cancer Radiotherapy Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cancer Radiotherapy by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Cancer Radiotherapy by Application (2023-2028)
10.3 Cancer Radiotherapy Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cancer Radiotherapy by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Cancer Radiotherapy by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Cancer Radiotherapy Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Cancer Radiotherapy Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Cancer Radiotherapy Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Cancer Radiotherapy Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Cancer Radiotherapy Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Cancer Radiotherapy Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Cancer Radiotherapy Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Cancer Radiotherapy Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Cancer Radiotherapy Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Cancer Radiotherapy Manufacturing Sites and Area Served
    Table 11. Manufacturers Cancer Radiotherapy Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Cancer Radiotherapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Radiotherapy as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Cancer Radiotherapy Sales by Region (2017-2022) & (K Units)
    Table 16. Global Cancer Radiotherapy Sales Market Share by Region (2017-2022)
    Table 17. Global Cancer Radiotherapy Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Cancer Radiotherapy Revenue Market Share by Region (2017-2022)
    Table 19. North America Cancer Radiotherapy Sales by Country (2017-2022) & (K Units)
    Table 20. North America Cancer Radiotherapy Sales Market Share by Country (2017-2022)
    Table 21. North America Cancer Radiotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Cancer Radiotherapy Revenue Market Share by Country (2017-2022)
    Table 23. Europe Cancer Radiotherapy Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Cancer Radiotherapy Sales Market Share by Country (2017-2022)
    Table 25. Europe Cancer Radiotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Cancer Radiotherapy Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Cancer Radiotherapy Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Cancer Radiotherapy Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Cancer Radiotherapy Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Cancer Radiotherapy Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Cancer Radiotherapy Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Cancer Radiotherapy Sales Market Share by Country (2017-2022)
    Table 33. Latin America Cancer Radiotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Cancer Radiotherapy Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Cancer Radiotherapy Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Cancer Radiotherapy Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Cancer Radiotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Cancer Radiotherapy Revenue Market Share by Country (2017-2022)
    Table 39. Global Cancer Radiotherapy Sales by Type (2017-2022) & (K Units)
    Table 40. Global Cancer Radiotherapy Sales Market Share by Type (2017-2022)
    Table 41. Global Cancer Radiotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Cancer Radiotherapy Revenue Share by Type (2017-2022)
    Table 43. Global Cancer Radiotherapy Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Cancer Radiotherapy Sales (K Units) by Application (2017-2022)
    Table 45. Global Cancer Radiotherapy Sales Market Share by Application (2017-2022)
    Table 46. Global Cancer Radiotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Cancer Radiotherapy Revenue Share by Application (2017-2022)
    Table 48. Global Cancer Radiotherapy Price by Application (2017-2022) & (US$/Unit)
    Table 49. Siemens Healthineers Corporation Information
    Table 50. Siemens Healthineers Description and Business Overview
    Table 51. Siemens Healthineers Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Siemens Healthineers Cancer Radiotherapy Product
    Table 53. Siemens Healthineers Recent Developments/Updates
    Table 54. Elekta Corporation Information
    Table 55. Elekta Description and Business Overview
    Table 56. Elekta Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Elekta Cancer Radiotherapy Product
    Table 58. Elekta Recent Developments/Updates
    Table 59. Accuray Incorporated Corporation Information
    Table 60. Accuray Incorporated Description and Business Overview
    Table 61. Accuray Incorporated Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Accuray Incorporated Cancer Radiotherapy Product
    Table 63. Accuray Incorporated Recent Developments/Updates
    Table 64. IBA Corporation Information
    Table 65. IBA Description and Business Overview
    Table 66. IBA Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. IBA Cancer Radiotherapy Product
    Table 68. IBA Recent Developments/Updates
    Table 69. ViewRay Technologies Corporation Information
    Table 70. ViewRay Technologies Description and Business Overview
    Table 71. ViewRay Technologies Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. ViewRay Technologies Cancer Radiotherapy Product
    Table 73. ViewRay Technologies Recent Developments/Updates
    Table 74. Hitachi Ltd. Corporation Information
    Table 75. Hitachi Ltd. Description and Business Overview
    Table 76. Hitachi Ltd. Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Hitachi Ltd. Cancer Radiotherapy Product
    Table 78. Hitachi Ltd. Recent Developments/Updates
    Table 79. iCAD, Inc. Corporation Information
    Table 80. iCAD, Inc. Description and Business Overview
    Table 81. iCAD, Inc. Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. iCAD, Inc. Cancer Radiotherapy Product
    Table 83. iCAD, Inc. Recent Developments/Updates
    Table 84. IsoRay Corporation Information
    Table 85. IsoRay Description and Business Overview
    Table 86. IsoRay Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. IsoRay Cancer Radiotherapy Product
    Table 88. IsoRay Recent Developments/Updates
    Table 89. Mevion Medical Systems Corporation Information
    Table 90. Mevion Medical Systems Description and Business Overview
    Table 91. Mevion Medical Systems Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Mevion Medical Systems Cancer Radiotherapy Product
    Table 93. Mevion Medical Systems Recent Developments/Updates
    Table 94. Panacea Medical Technologies Corporation Information
    Table 95. Panacea Medical Technologies Description and Business Overview
    Table 96. Panacea Medical Technologies Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Panacea Medical Technologies Cancer Radiotherapy Product
    Table 98. Panacea Medical Technologies Recent Developments/Updates
    Table 99. P-cure Ltd. Corporation Information
    Table 100. P-cure Ltd. Description and Business Overview
    Table 101. P-cure Ltd. Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. P-cure Ltd. Cancer Radiotherapy Product
    Table 103. P-cure Ltd. Recent Developments/Updates
    Table 104. ZEISS Group Corporation Information
    Table 105. ZEISS Group Description and Business Overview
    Table 106. ZEISS Group Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. ZEISS Group Cancer Radiotherapy Product
    Table 108. ZEISS Group Recent Developments/Updates
    Table 109. Production Base and Market Concentration Rate of Raw Material
    Table 110. Key Suppliers of Raw Materials
    Table 111. Cancer Radiotherapy Distributors List
    Table 112. Cancer Radiotherapy Customers List
    Table 113. Cancer Radiotherapy Market Trends
    Table 114. Cancer Radiotherapy Market Drivers
    Table 115. Cancer Radiotherapy Market Challenges
    Table 116. Cancer Radiotherapy Market Restraints
    Table 117. Global Cancer Radiotherapy Sales Forecast by Type (2023-2028) & (K Units)
    Table 118. Global Cancer Radiotherapy Sales Market Share Forecast by Type (2023-2028)
    Table 119. Global Cancer Radiotherapy Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 120. Global Cancer Radiotherapy Revenue Market Share Forecast by Type (2023-2028)
    Table 121. Global Cancer Radiotherapy Sales Forecast by Application (2023-2028) & (K Units)
    Table 122. Global Cancer Radiotherapy Sales Market Share Forecast by Application (2023-2028)
    Table 123. Global Cancer Radiotherapy Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 124. Global Cancer Radiotherapy Revenue Market Share Forecast by Application (2023-2028)
    Table 125. Global Cancer Radiotherapy Sales Forecast by Region (2023-2028) & (K Units)
    Table 126. Global Cancer Radiotherapy Sales Market Share Forecast by Region (2023-2028)
    Table 127. Global Cancer Radiotherapy Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 128. Global Cancer Radiotherapy Revenue Market Share Forecast by Region (2023-2028)
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Cancer Radiotherapy
    Figure 2. Global Cancer Radiotherapy Market Share by Type in 2021 & 2028
    Figure 3. External Beam Radiotherapy Product Picture
    Figure 4. Internal Beam Radiotherapy Product Picture
    Figure 5. Systemic Radiotherapy Product Picture
    Figure 6. Intravenous Radiotherapy Product Picture
    Figure 7. Oral Radiotherapy Product Picture
    Figure 8. Instillation Radiotherapy Product Picture
    Figure 9. Global Cancer Radiotherapy Market Share by Application in 2021 & 2028
    Figure 10. Hospitals
    Figure 11. Independent Radiotherapy Centers
    Figure 12. Global Cancer Radiotherapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Cancer Radiotherapy Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Cancer Radiotherapy Sales (2017-2028) & (K Units)
    Figure 15. Cancer Radiotherapy Sales Share by Manufacturers in 2021
    Figure 16. Global Cancer Radiotherapy Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Cancer Radiotherapy Players: Market Share by Revenue in 2021
    Figure 18. Cancer Radiotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Cancer Radiotherapy Sales Market Share by Region (2017-2022)
    Figure 20. Global Cancer Radiotherapy Sales Market Share by Region in 2021
    Figure 21. Global Cancer Radiotherapy Revenue Market Share by Region (2017-2022)
    Figure 22. Global Cancer Radiotherapy Revenue Market Share by Region in 2021
    Figure 23. United States Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. China Taiwan Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Mexico Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Brazil Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Argentina Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Colombia Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Turkey Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Saudi Arabia Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. UAE Cancer Radiotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Sales Market Share of Cancer Radiotherapy by Type (2017-2022)
    Figure 47. Manufacturing Cost Structure of Cancer Radiotherapy
    Figure 48. Manufacturing Process Analysis of Cancer Radiotherapy
    Figure 49. Cancer Radiotherapy Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Colon Cancer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-31C5944
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10J13802
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Color Detection Sensors Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6G9623
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Appendix Cancer Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2H1312
Mon Apr 15 00:00:00 UTC 2024

Add to Cart